Abstract
Purpose
18F-FDG PET/CT (PET/CT) is a useful tool for the diagnosis of aortic graft infection (AGI), but has rarely been used to influence therapeutic decisions during follow-up. We aimed to study the role of PET/CT in the long-term monitoring of patients.
Methods
Participants of the prospective Vascular Graft Infection Cohort Study (VASGRA) were included if they had microbiologically proven AGI. We quantified the metabolic activity in PET/CT by using maximum standardized uptake value (SUVmax) and further classified it as being focal or diffuse. Multivariable linear regression models were fit using generalized estimating equations to investigate factors associated with SUVmax over time.
Results
Sixty-eight participants with AGI contributed to 266 PET/CTs including 36 examinations performed after stop of antimicrobial therapy. Higher C-reactive protein (CRP) (adjusted coefficient per log10 mg/L 0.05 [95% C.I. 0.02–0.08]) was associated with higher SUVmax. CRP, metabolic and clinical findings informed the decision to either start (medians of SUVmax 7.1 and CRP 31.5 mg/L; 100% focal uptake), escalate (SUVmax 9.5; CRP 31.5; 100% focal uptake), continue (SUVmax 6.0; CRP 9.95 mg/L; 90% focal uptake), or stop (SUVmax 4.3; CRP 3.5 mg/L; 61% focal uptake) antibiotic treatment. Of note, decisions to escalate or continue antibiotic treatment were taken despite normal CRP values in 12.5 and 35.7% of PET/CTs, respectively.
Conclusions
Consecutive PET/CTs could influence the clinical decision-making in patients with AGI in the near future. More studies on the use of PET/CT in case of aortic graft infection may offer the potential for individualized treatment approaches.
CLINICALTRIALS.GOV IDENTIFIER
NCT01821664.
Similar content being viewed by others
References
Legout L, Sarraz-Bournet B, D'Elia PV, Devos P, Pasquet A, Caillaux M, et al. Characteristics and prognosis in patients with prosthetic vascular graft infection: a prospective observational cohort study. Clin Microbiol Infect. 2011. https://doi.org/10.1111/j.1469-0691.2011.03618.x.
Hasse B, Husmann L, Zinkernagel A, Weber R, Lachat M, Mayer D. Vascular graft infections. Swiss Med Wkly. 2013;143:w13754. https://doi.org/10.4414/smw.2013.13754.
Wilson WR, Bower TC, Creager MA, Amin-Hanjani S, O'Gara PT, Lockhart PB, et al. Vascular Graft Infections, Mycotic Aneurysms, and Endovascular Infections: A Scientific Statement From the American Heart Association. Circulation. 2016;134:e412–e60. https://doi.org/10.1161/CIR.0000000000000457.
Antonios VS, Noel AA, Steckelberg JM, Wilson WR, Mandrekar JN, Harmsen WS, et al. Prosthetic vascular graft infection: a risk factor analysis using a case-control study. J Inf Secur. 2006;53:49–55. https://doi.org/10.1016/j.jinf.2005.10.004.
Turtiainen J, Saimanen E, Partio T, Karkkainen J, Kiviniemi V, Makinen K, et al. Surgical wound infections after vascular surgery: prospective multicenter observational study. Scand J Surg. 2010;99:167–72. https://doi.org/10.1177/145749691009900312.
Vogel TR, Symons R, Flum DR. The incidence and factors associated with graft infection after aortic aneurysm repair. J Vasc Surg. 2008;47:264–9. https://doi.org/10.1016/j.jvs.2007.10.030.
Low RN, Wall SD, Jeffrey RB, Jr., Sollitto RA, Reilly LM, Tierney LM, Jr. Aortoenteric fistula and perigraft infection: evaluation with CT. Radiology 1990;175:157–162. https://doi.org/10.1148/radiology.175.1.2315475.
Mark A, Moss AA, Lusby R, Kaiser JA. CT evaluation of complications of abdominal aortic surgery. Radiology. 1982;145:409–14. https://doi.org/10.1148/radiology.145.2.6982487.
Fiorani P, Speziale F, Rizzo L, De Santis F, Massimi GJ, Taurino M, et al. Detection of aortic graft infection with leukocytes labeled with technetium 99m-hexametazime. J Vasc Surg. 1993;17:87–95. discussion -6
Bruggink JL, Glaudemans AW, Saleem BR, Meerwaldt R, Alkefaji H, Prins TR, et al. Accuracy of FDG-PET-CT in the diagnostic work-up of vascular prosthetic graft infection. European Journal of Vascular and Endovascular Surgery: The Official Journal of the European Society for Vascular Surgery. 2010;40:348–54. https://doi.org/10.1016/j.ejvs.2010.05.016.
Fukuchi K, Ishida Y, Higashi M, Tsunekawa T, Ogino H, Minatoya K, et al. Detection of aortic graft infection by fluorodeoxyglucose positron emission tomography: comparison with computed tomographic findings. J Vasc Surg. 2005;42:919–25. https://doi.org/10.1016/j.jvs.2005.07.038.
Keidar Z, Engel A, Hoffman A, Israel O, Nitecki S. Prosthetic vascular graft infection: the role of 18F-FDG PET/CT. Journal of Nuclear Medicine: Official Publication, Society of Nuclear Medicine. 2007;48:1230–6. https://doi.org/10.2967/jnumed.107.040253.
Sah BR, Husmann L, Mayer D, Scherrer A, Rancic Z, Puippe G, et al. Diagnostic Performance of F-FDG-PET/CT in Vascular Graft Infections. European Journal of Vascular and Endovascular Surgery: the Official Journal of the European Society for Vascular Surgery. 2015. https://doi.org/10.1016/j.ejvs.2014.12.024.
Husmann L, Sah BR, Scherrer A, Burger IA, Stolzmann P, Weber R, et al. (1)(8)F-FDG PET/CT for Therapy Control in Vascular Graft Infections: A First Feasibility Study. J Nucl Med. 2015;56:1024–9. https://doi.org/10.2967/jnumed.115.156265.
Lyons OT, Baguneid M, Barwick TD, Bell RE, Foster N, Homer-Vanniasinkam S, et al. Diagnosis of Aortic Graft Infection: A Case Definition by the Management of Aortic Graft Infection Collaboration (MAGIC). Eur J Vasc Endovasc Surg. 2016;52:758–63. https://doi.org/10.1016/j.ejvs.2016.09.007.
Samson RH, Veith FJ, Janko GS, Gupta SK. Scher LA. A modified classification and approach to the management of infections involving peripheral arterial prosthetic grafts. J Vasc Surg. 1988;8:147–53.
Mayer D, Hasse B, Koelliker J, Enzler M, Veith FJ, Rancic Z, et al. Long-term results of vascular graft and artery preserving treatment with negative pressure wound therapy in Szilagyi grade III infections justify a paradigm shift. Ann Surg. 2011;254:754–9; discussion 60. https://doi.org/10.1097/SLA.0b013e3182365864.
Ankrah AO, Glaudemans A, Klein HC, Dierckx R, Sathekge M. The Role of Nuclear Medicine in the Staging and Management of Human Immune Deficiency Virus Infection and Associated Diseases. Nucl Med Mol Imaging. 2017;51:127–39. https://doi.org/10.1007/s13139-016-0422-0.
Seban RD, Bonardel G, Guernou M, Lussato D, Queneau M. The Use of FDG PET-CT Imaging for the Assessment of Early Antifungal Treatment Response in Disseminated Fusariosis. Clin Nucl Med. 2017;42:569–70. https://doi.org/10.1097/RLU.0000000000001682.
Dejust S, Guedec-Ghelfi R, Blanc-Autrant E, Lepers Y, Morland D. Infection of Ventricular Assist Device Detected and Monitored by 18F-FDG PET/CT. Clin Nucl Med. 2017. https://doi.org/10.1097/RLU.0000000000001736.
Chacko AM, Watanabe S, Herr KJ, Kalimuddin S, Tham JY, Ong J, et al. 18F-FDG as an inflammation biomarker for imaging dengue virus infection and treatment response. JCI Insight. 2017;2 https://doi.org/10.1172/jci.insight.93474.
Lefebvre N, Argemi X, Meyer N, Mootien J, Douiri N, Sferrazza-Mandala S, et al. Clinical usefulness of 18F-FDG PET/CT for initial staging and assessment of treatment efficacy in patients with lymph node tuberculosis. Nucl Med Biol. 2017;50:17–24. https://doi.org/10.1016/j.nucmedbio.2017.04.003.
Machelart I, Greib C, Wirth G, Camou F, Issa N, Viallard JF, et al. Graft infection after a Bentall procedure: A case series and systematic review of the literature. Diagn Microbiol Infect Dis. 2017;88:158–62. https://doi.org/10.1016/j.diagmicrobio.2017.03.002.
Deipolyi AR, Rho J, Khademhosseini A, Oklu R. Diagnosis and management of mycotic aneurysms. Clin Imaging. 2016;40:256–62. https://doi.org/10.1016/j.clinimag.2015.11.011.
Kagna O, Kurash M, Ghanem-Zouabi N, Keidar Z, Israel O. Does antibiotic treatment affect the diagnostic accuracy of FDG PET/CT studies in patients with suspected infectious processes? Journal of Nuclear Medicine: Official Publication, Society of Nuclear Medicine. 2017. https://doi.org/10.2967/jnumed.117.192062.
Spacek M, Belohlavek O, Votrubova J, Sebesta P, Stadler P. Diagnostics of "non-acute" vascular prosthesis infection using 18F-FDG PET/CT: our experience with 96 prostheses. Eur J Nucl Med Mol Imaging. 2009;36:850–8. https://doi.org/10.1007/s00259-008-1002-z.
Keidar Z, Pirmisashvili N, Leiderman M, Nitecki S, Israel O. 18F-FDG Uptake in Noninfected Prosthetic Vascular Grafts: Incidence, Patterns, and Changes over Time. Journal of Nuclear Medicine: Official Publication, Society of Nuclear Medicine. 2014;55:392–5. https://doi.org/10.2967/jnumed.113.128173.
Rabkin Z, Israel O, Keidar Z. Do hyperglycemia and diabetes affect the incidence of false-negative 18F-FDG PET/CT studies in patients evaluated for infection or inflammation and cancer? A Comparative analysis. Journal of Nuclear Medicine: Official Publication, Society of Nuclear Medicine. 2010;51:1015–20. https://doi.org/10.2967/jnumed.109.074294.
Acknowledgements
We are grateful to our patients for their commitment and thank B. Ruehe, C. Rüegg, A. Wolfensberger, U. Matt, M. Kälin and M. Greiner for excellent patient care. We also thank C. Müller and S. Bürgin, study nurses and C. Vögtli for administrative assistance.
The members of the VASGRA Cohort Study are (in alphabetical order): A. Anagnosto-poulos, B. Hasse (Principle investigator), L. Husmann, B. Ledergerber, M. Lachat, D. Mayer, Z. Rancic, A. Scherrer, A. Weber, R. Weber, R. Zbinden, A. Zinkernagel.
Funding
This study was financed within the framework of the Vascular Graft Cohort Study (VASGRA), supported by the Swiss National Science Foundation (SNF) grant #32473B_163132/1, a SNF protected-research-time for clinicans grant #32473B_163132/2; the Vontobel Foundation and the Rozalia Foundation (all to BH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Author information
Authors and Affiliations
Consortia
Contributions
BH and LH designed the study. BL analyzed the data. LH and BH wrote the first draft, and LH, BL, AA and BH wrote the final version of the manuscript. All investigators contributed to collection and interpretation of the data, reviewed drafts of the manuscript, and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of Interest
All authors declare no conflicts of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The Institutional Review Board approved the study, and we obtained written informed consent from all participants (KEK-ZH-Nr. 2012–0583).
Electronic supplementary material
ESM 1
(PDF 129 kb)
Rights and permissions
About this article
Cite this article
Husmann, L., Ledergerber, B., Anagnostopoulos, A. et al. The role of FDG PET/CT in therapy control of aortic graft infection. Eur J Nucl Med Mol Imaging 45, 1987–1997 (2018). https://doi.org/10.1007/s00259-018-4069-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00259-018-4069-1